Search Results 4131-4140 of 25404 for oral
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...
8 weeks before screening start for oral estrogen and/or progestin products and/or selective estrogen receptor modulator therapy; 4. 8 weeks before screening ...
The purpose of this study is to evaluate the effect of oral midodrine administration on vasopressor-free days in patients with septic shock (primary outcome).
Second Place, Lightning Oral Poster Presentation: "Ultrasound for Fractures"Southeastern Society of Academic Emergency Medicine. 2012. Exemplary ...
This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in ...
Departments that treat this condition. Cancer Care at Mayo Clinic · Children's Center · Head and Neck Cancer Center · Neurosurgery · Oncology (Medical) · Oral ...
... oral, intravaginal, or transdermal 2. Progestogen-only hormonal contraception associated with inhibition of ovulation: oral, injectable, or implantable 3 ...
The main objective is to assess long term safety of treatment with oral nintedanib in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.